205 related articles for article (PubMed ID: 20472270)
1. MicroRNAs: a new paradigm on molecular urological oncology.
Reis LO; Pereira TC; Lopes-Cendes I; Ferreira U
Urology; 2010 Sep; 76(3):521-7. PubMed ID: 20472270
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K
Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772
[TBL] [Abstract][Full Text] [Related]
3. [Application of microRNAs to Cancer Therapy].
Iguchi H; Ochiya T
Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
[TBL] [Abstract][Full Text] [Related]
4. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Tong AW; Nemunaitis J
Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
6. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
Spizzo R; Rushworth D; Guerrero M; Calin GA
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
[TBL] [Abstract][Full Text] [Related]
7. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
Rexer H
Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
[No Abstract] [Full Text] [Related]
8. miRNA: the new gene silencer.
Ross JS; Carlson JA; Brock G
Am J Clin Pathol; 2007 Nov; 128(5):830-6. PubMed ID: 17951207
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
Boni V; Bandres E; Zarate R; Colucci G; Maiello E; Garcia-Foncillas J
Oncology; 2009; 77 Suppl 1():75-89. PubMed ID: 20130435
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiling in cancer from a bioinformatics prospective.
Gusev Y; Brackett DJ
Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
[TBL] [Abstract][Full Text] [Related]
12. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Kent OA; Mendell JT
Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
[TBL] [Abstract][Full Text] [Related]
13. Slowing down the Ras lane: miRNAs as tumor suppressors?
Morris JP; McManus MT
Sci STKE; 2005 Aug; 2005(297):pe41. PubMed ID: 16107327
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
Lowery AJ; Miller N; McNeill RE; Kerin MJ
Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
[TBL] [Abstract][Full Text] [Related]
15. RNAi, microRNAs, and human disease.
Hammond SM
Cancer Chemother Pharmacol; 2006 Nov; 58 Suppl 1():s63-8. PubMed ID: 17093929
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and cancer.
Cowland JB; Hother C; Grønbaek K
APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
[TBL] [Abstract][Full Text] [Related]
17. Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases.
Kolfschoten IG; Regazzi R
Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):827-34. PubMed ID: 18026161
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS; Dutta A
Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
[TBL] [Abstract][Full Text] [Related]
19. Rethinking the central dogma: noncoding RNAs are biologically relevant.
Robinson VL
Urol Oncol; 2009; 27(3):304-6. PubMed ID: 19414118
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression and function in cancer.
Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
